{"id":"W4283394029","doi":"10.1017/cjn.2022.123","title":"P.020 Long-term safety and tolerability of atogepant 60mg once daily for preventive treatment of migraine: a phase 3, 40-week, multicenter extension to the advance trial","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Tolerability; Discontinuation; Medicine; Adverse effect; Nausea; Dosing; Migraine; Internal medicine; Clinical trial","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001395283,0.0003593897,0.0003899976,0.0001801051,0.0003691359,0.0009026625,0.0004038496,0.0009130307,0.08891807],"category_scores_gemma":[0.002523632,0.0001444809,0.0006543788,0.0003733526,0.0004064584,0.0005188299,0.0002807892,0.00172689,0.009532227],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002959566,"about_ca_system_score_gemma":0.0009867859,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004817633,"about_ca_topic_score_gemma":0.0006376587,"domain_scores_codex":[0.9994786,0.0001835978,0.00002785979,0.00008154503,0.0001408641,0.00008756501],"domain_scores_gemma":[0.9982058,0.0006804267,0.0002559152,0.00008889551,0.0003432384,0.0004256998],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2425538,0.003599294,0.05069283,0.003043464,0.002599264,0.001129853,0.0002915621,0.0007810086,0.01207602,0.00493647,0.3922407,0.2860558],"study_design_scores_gemma":[0.1241781,0.056256,0.3291996,0.001414174,0.002968288,0.003274131,0.000424663,0.004267976,0.007108435,0.01181347,0.4589892,0.000106044],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5027076,0.0287796,0.006203002,0.042218,0.01332657,0.003194095,0.0311755,0.0008257417,0.3715699],"genre_scores_gemma":[0.8800898,0.004149339,0.00399358,0.0108418,0.006192523,0.002614289,0.007264462,0.0002045653,0.08464978],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08891807,"threshold_uncertainty_score":0.2974606,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05995600653016777,"score_gpt":0.3444526427021459,"score_spread":0.2844966361719781,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}